English | 繁體

Search in the results

UM

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
CDK inhibitors from past to present: A new wave of cancer therapy Journal article
Muhammad Jameel Mughal, Kinjal Bhadresha, Hang Fai Kwok. CDK inhibitors from past to present: A new wave of cancer therapy[J]. Seminars in Cancer Biology, 2023, 88, 106-122.
Authors:  Muhammad Jameel Mughal;  Kinjal Bhadresha;  Hang Fai Kwok
Favorite | TC[WOS]:38 TC[Scopus]:38  IF:12.1/13.2 | Submit date：2023/02/08
Cancer Therapeutic Regimen  Cell Cycle  Combination Treatment  Cyclin-dependent Kinase Inhibitor  
Chaetominine induces cell cycle arrest in human leukemia K562 and colon cancer SW1116 cells Journal article
Yao, Jingyun, Xiao, Jianbo, Wei, Xing, Lu, Yanhua. Chaetominine induces cell cycle arrest in human leukemia K562 and colon cancer SW1116 cells[J]. ONCOLOGY LETTERS, 2018, 16(4), 4671-4678.
Authors:  Yao, Jingyun;  Xiao, Jianbo;  Wei, Xing;  Lu, Yanhua
Favorite | TC[WOS]:7 TC[Scopus]:8  IF:2.5/2.4 | Submit date：2018/10/30
Cell Cycle Arrest  Cyclin  Cyclin-dependent Kinase  Chaetominine  K562 Cells  Sw1116 Cells  
Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression Journal article
Wang, Yitao, Qin, Xian, Guo, Tao, Liu, Pengpeng, Wu, Ping, Liu, Zhisu. Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression[J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36.
Authors:  Wang, Yitao;  Qin, Xian;  Guo, Tao;  Liu, Pengpeng;  Wu, Ping; et al.
Favorite | TC[WOS]:19 TC[Scopus]:23 | Submit date：2018/11/01
Hepatocellular Carcinoma (Hcc)  Cyclin Dependent Kinase 16 (Cdk16)  Epithelial Mesenchymal Transition (Emt)  E2f1 Transcription Factor  Mir-125b-5p  
Research progress on effects of indirubin and its structurally similar compounds on anticancer and neuroprotection Journal article
Wang,Ying, Sa,Fei, Chan,Yuet Wa, Lee,Ming Yuen. Research progress on effects of indirubin and its structurally similar compounds on anticancer and neuroprotection[J]. Chinese Traditional and Herbal Drugs, 2014, 45(16), 2404-2411.
Authors:  Wang,Ying;  Sa,Fei;  Chan,Yuet Wa;  Lee,Ming Yuen
Favorite | TC[Scopus]:3 | Submit date：2021/03/02
Anticancer  Cyclin-dependent Kinases  Glycogen Synthase Kinase-3  Indirubin  Neurodegeneration Disease  
The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition Journal article
Xia Q., Cai Y., Peng R., Wu G., Shi Y., Jiang W.. The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition[J]. International Journal of Oncology, 2014, 44(3), 735.
Authors:  Xia Q.;  Cai Y.;  Peng R.;  Wu G.;  Shi Y.; et al.
Favorite | TC[WOS]:46 TC[Scopus]:49 | Submit date：2018/10/30
Brca1  Breast Cancer  Cyclin-dependent Kinase 1  Poly (Adp-ribose) Polymerase Inhibitor